Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1801 to 1825 of about 5940

Previous 25

Website Changes

12/15/2015

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

12/14/2015

New Data on Tumor Treating Fields’ Anti-Mitotic Mechanism of Action Published in Scientific Reports

12/14/2015

Roche`s Alecensa Granted Accelerated FDA Approval in Lung Cancer

12/13/2015

Patient with Brain Tumor Responds Dramatically to Targeted Therapy

12/12/2015

The Musella Foundation has awarded a pediatric brain tumor research grant

12/12/2015

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.

12/12/2015

First Patient Enrolled in Toca 5, Tocagen’s Phase 2/3 Clinical Trial in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma

12/08/2015

Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients

11/27/2015

Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme

11/27/2015

Experimental brain cancer treatment offers family hope

11/25/2015

The Musella Foundation announced that it has awarded a $50,000 brain tumor research grant to Ninh Doan, MD, PhD, of the Medical College of Wisconsin.

11/23/2015

Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs PFS but not OS

11/23/2015

Tocagen Presents Interim Data from Studies Evaluating Toca 511 & Toca FC at the Annual Meeting of the Society for Neuro-Oncology (SNO)

11/22/2015

Groundbreaking Global Brain Cancer Trial Planned

11/21/2015

ReACT: Long-term survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma

11/21/2015

Phase I/II Study of Dianhydrogalactitol (Val-083) in Patients with Recurrent Malignant Glioma

11/20/2015

Celldex vaccine improves long-term brain cancer survival in study

11/20/2015

New Phase 3 Data show Optune in Combination with Second Line Chemotherapy is Superior to Second Line Chemotherapy Alone in Glioblastoma Patients at First Recurrence

11/20/2015

ImmunoCellular Therapeutics Ltd Presents Updated ICT-107 Phase 2 Survival and Immune Response Data at the Society for Neuro-Oncology Annual Meeting 2015

11/18/2015

CURE Media Group’s Heroes of Glioblastoma Announced Today

11/18/2015

11/17/2015

Global brain cancer trial aims to rapidly respond to new treatments

11/17/2015

Drug That Could Limit Spread of Deadly Brain Tumours

11/17/2015

Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data

11/07/2015

Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.

Our privacy / cookie policy has changed.
Click HERE to read it!